Clinical Trial Update: A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cariprazine for preventing relapse in Bipolar I Disorder patients currently in manic or depressive episodes (with or without mixed fe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Mania

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Bipolar I Disorder, Mania | Phase 3 | Status: COMPLETED | Results posted: 2023-09-28